The cluster shows modest net selling by asset managers with no insider buying to offset it. Monitor upcoming Q3 earnings and any pipeline updates for Sarepta's Duchenne muscular dystrophy therapies, as the selling may reflect sector rotation or risk reduction ahead of results.
SRPT drugs
SRPT drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 3 $18.54entry
- T+1 · 13d ago +2.43%α +0.78% · $18.99
- T+5 · 7d ago −11.43%α −10.85% · $16.42
- T+9 · todayOpen
- T+20 · in 15d Pending
- T+60 · in 3mo Pending
How similar events traded
Executive Summary
Three asset managers added small positions in Sarepta Therapeutics during Q3 2026, while three others trimmed, led by Mackenzie Financial reducing its stake by $6.0M. The net institutional activity was negative ($5.2M net selling), and no insider buying corroborates the cluster. The mixed signals and 45-day reporting lag limit the near-term read-through.
Key Financial Metrics
Institutional Positions
Net institutional flow: -$5.2M
▲ Buyers (3)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Creative Planning | ADD | +71.8% | $2.0M | $832.0K |
| Alps Advisors | ADD | +31.3% | $2.5M | $635.0K |
| Nisa Investment Advisors | ADD | +40% | $83.0K | $25.0K |
▼ Sellers (3)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Mackenzie Financial | TRIM | -56.2% | $10.8M | -$6.0M |
| Farther Finance Advisors | TRIM | -52.4% | $42.0K | -$22.0K |
| Wealth Enhancement Advisory Services | TRIM | -64.8% | $1.0M | -$689.0K |
Key Facts
- 3 buyers added $1.5M in net new holdings (total current value $4.6M)
- 3 sellers reduced holdings by $6.7M (net selling of $5.2M across all 6 funds)
- Mackenzie Financial was the largest seller, trimming 56.2% of its stake ($6.0M reduction)
- No open-market insider buying detected in the same window (confluence score 19/100)
- All six funds are asset managers; no activist or hedge fund involvement
- 13F data is as of quarter-end 2026-Q3, filed with a 45-day lag
Financial Impact
Net institutional selling of $5.2M across 6 funds; largest single move was Mackenzie Financial's $6.0M reduction
Risk Factors
- 13F data is stale (45-day lag); positions may have changed since quarter-end
- All funds are asset managers; no high-conviction activist or hedge fund involvement
- Net selling of $5.2M is small relative to $2.0B market cap (0.26%)
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-SRPT-2026-Q3 |
Track record
9 reports on SRPT
Filters
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $16.07 settles Dec 14
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $16.42 settles Dec 9
- Nov 5, 202611d ago 8-K Neutral 5/10 Entry $17.82 settles Dec 7
- Nov 3, 202613d ago Institutional Cluster Neutral 2/10 Viewing Entry $18.54 settles Dec 2
- Jul 27, 202616w ago 8-K Neutral 3/10 Entry $15.89 to $18.13 ▲ +14.10% +10.80% vs SPY
- Jun 11, 202622w ago Institutional Cluster Mixed 4/10 Entry $15.00 to $20.52 ▲ +36.80% +34.91% vs SPY
- Jun 4, 202623w ago 8-K Neutral 3/10 Entry $15.75 to $19.18 ▲ +21.78% +19.92% vs SPY
- Apr 24, 202629w ago DEFA14A Neutral 3/10 Entry $20.89 to $16.67 ▼ −20.18% −25.14% vs SPY
- Feb 25, 202637w ago 8-K Mixed 7/10 Entry $17.45 to $21.68 ▲ +24.24% +30.65% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers